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1. Introduction 
Heat therapy is a traditional healing method. The first written reference to hyperthermia 
occurred in an Egyptian papyrus scroll 5000 years ago (Hall & Cox, 2003). In this chapter, 
we planned to introduce promising medical treatments which applied thermal energy in 
living tissues to raise tissue temperatures to therapeutic temperatures. The treatments, based 
on duration of time, were classified into low-temperature level in the range of 41~45°C 
(hyperthermia or thermal therapy) and much higher temperatures (thermal ablation 
treatments) than previous one.  
Heating in the biothermal systems involves two primary heat transport modes: thermal 
conduction and convection. Extreme complicating living vasculatures and organs make 
heating the target volume and raising temperature to therapeutic temperature at the target 
volume difficult and, thus, a challenging task.  
In this chapter, we will introduce thermal models which were used to describe biothermal 
systems. One of well-known models, Pennes bio-heat transfer equation (PBHTE) was 
initially introduced in 1949. Up until now, it still is used widely by research groups around 
the globe, to deal with temperature or heat that associated with human or living creatures. 
As well as other models which also described the impact of thermally significant blood 
vessel (or vascular system) and blood perfusion during treatments will also be introduced in 
this chapter. 
The heating methods that deposited the thermal energy in transport medium (i.e. solid 
tumor, tissues and liquid so forth) will also be addressed. For example, high-intensity 
focused ultrasound (HIFU) is one of popular non-invasive method which could deposit heat 
into deep seated tissue region. 
Lastly, we addressed promising future in combining other treating modalities (such as drug 
treatment) with hyperthermia. It has shown significant results for medical treatments in 
curing patients with cancers.  
2. Heat transport 
Thermal transport modes in bio-thermal systems involve three typical modes: conduction, 
convection and radiation. Limitation and restrictions of therapeutic temperatures on heating 
(or freezing) subjects are first, to remove tumorous tissues and at the same time without 
damaging the normal tissues. Table 1 shows significance of thermal transport modes in  
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typical components of bio-thermal systems, as our subject of discussion refers to cancer 
treatments using heat. Thermal diffusion plays a dominant transport mode in tissues, and 
convection is less significant as blood perfuses in solid tissues at capillary level vessels 
which are small in size and blood within are in slow motion. 
 
 Conduction  Convection  Radiation 
Tissues Significant  Less Significant Insignificant 
Bones Significant Insignificant  Insignificant 
Blood vessels Less Significant Significant  Insignificant 
Skins Insignificant Significant Significant 
Table 1. Significance of thermal transport modes in typical components of vio-thermal 
systems 
3. Mathematical modelings 
To accurately describe physical phenomena in living tissues, we have to rely upon 
mathematical models (or bio-heat transfer formulation). There are many significant models 
appeared in history during the development of heating in tissues. Those models help us in 
analyzing temperature management in treatment planning with accuracy. We introduced 
them here: 
3.1 Pennes bio-heat transfer equation (PBHTE) 
In 1948, Pennes (Pennes, 1948) performed a series of experiments which measured 
temperatures on human forearms of volunteers, and derived a thermal energy conservation 
equation: the well known bio-heat transfer equation (BHTE) or the traditional bio-heat 
transfer equation. It is written as 
 ( )p m b a p
T
k T q q Wc T T c
t
ρ ∂∇ ∇ + + − − = ∂i  (1) 
where T(°>°C) is the local tissue temperature; Ta (°C) is the arterial temperature; cb 
(J/kg/°C) is the blood specific heat; cp (J/kg/°C) is the tissue specific heat; W(kg/m3/s) is 
the local tissue blood perfusion rate; k(w/m/°C) is the tissue thermal conductivity; 
ρ(kg/m3) is the tissue density; qp(w/m3) is the energy deposition rate; and qm (w/m3) is the 
metabolism, which is usually very small compared to the external power deposition term qp 
(Roemer et al, 1988). The term Wcb(T-Ta), which accounts for the effects of blood perfusion, 
can be the dominant form of energy removal when considering heating process. It assumes 
that the blood enters the control volume at some arterial temperature Ta, and then comes to 
equilibrium at the tissue temperature. Thus, the blood leaves the control volume it carries 
away the energy, and hence acts as an energy sink in hyperthermia treatment.  
Although Pennes’ equation is an approximation equation and it does not have a physically 
consistent theoretical basis, it is surprisingly that this simple mathematical formulation 
predicted temperature fields well in many application situations. The reasons why PBHTE 
has been widely used in hyperthermia modeling field are two important factors: one is its 
mathematical simplicity and the other is its ability to predict the temperature field 
reasonably in applied fields.  
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Nevertheless, the equation does have some limitations. It does not, nor was it ever intended 
to, handle several physical effects. The most significant problem is that it does not consider 
the effect of the directionality of blood flow, and hence does not describe any convective 
heat transfer mechanism. 
3.2 The Chen and Holmes (CH) model 
Several investigators have developed alternative formulations to predict temperatures in 
living tissues. In 1980, Chen and Holmes (Chen and Holmes, 1980) derived the one and it 
has a very strong physical and physiological basis. The equation can be written as, 
 
 ( ) ( )p p m b a b b p
T
k k T q q Wc T T c u T c
t
ρ ρ ∂∇ + ∇ + + − − − ∇ = ∂i i  (2) 
 
Comparing this equation with Pennes’ equation, two extra terms have been added. The term 
b bc u Tρ− ∇i  is the convective heat transfer term, which accounts for the thermal interactions 
between blood vessels and tissues. The term pk T∇ ∇i  accounts for the enhanced tissue 
conductive heat transfer due to blood perfusion term in tissues, where kp is called the 
perfusion conductivity, and is a function of blood perfusion rate. The blood perfusion term 
( )b aWc T T− −  shown in CH model, accounts for the effects of the large number of capillary 
structures whose individual dimensions are small relative to the macroscopic phenomenon 
under their study. Relatively CH model has a more solid physical basis than Pennes model. 
However, it requires knowledge of the details of the vascular anatomy and flow pattern to 
solve it, and that was an extreme complicating task.  
3.3 The Weinbaum and Jiji (WJ) model 
In 1985, Weinbaum and Jiji (Weinbaum and Jiji, 1985) proposed an alternative mathematical 
formulation of the bio-heat transfer equation. Their formulation is based on their 
observations from vascular network of rabbit thighs that blood vessels which are significant 
for heat transfer in tissues always occur in counter-current pairs. Hence, the major heat 
transfer mechanism between blood and tissues is the “incomplete counter-current heat 
exchanger” between thermally significant arteries and veins (with diameters about 50-
500μm). Their formulation uses tensor notation and it can be written as 
 
2 2 2
2( )
4
b i
ij eff j m
i j j j
na k l
c k Pe l Q
t x x k k x
πθ θ θρ σ
⎡ ⎤ ∂∂ ∂ ∂ ∂− = − +⎢ ⎥∂ ∂ ∂ ∂ ∂⎢ ⎥⎣ ⎦
 (3) 
where θ is the local temperature, cρ is the volume average tissue density and specific heat 
product, a is the local blood vessel radius, σ is a shape factor for the thermal conduction 
resistance between adjacent counter-current vessels, n is the number density of blood 
vessels of size a, kb is the blood thermal conductivity, Pe is the local Peclet number 
(=2 bρ cnau/kb), us is average blood flow velocity in the vessels and li is the direction cosine 
of the ith pair of countercurrent vessels. ( )ij effk  is the effective conductivity tenor element, 
which is given by, 
 
2 2 2
2
2
( ) ( )
4
b
ij eff ij i j
na k
k k Pe l l
k
πδ σ= +  (4) 
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where δij is the kronecker delta function, and k is the tissue thermal conductivity. Clearly, 
this equation represents one of the most significant contributions to the bio-heat transfer 
formulation. But, in practical situations, this equation needs detailed knowledge of the sizes, 
orientations, and blood flow velocities in the countercurrent vessels to solve it and that 
presents a formidable task. Furthermore, there are several issues related to the WJ model. 
First, thoroughly comparison for both predicted temperatures and macroscopic experiments 
are required. Secondly, the formulation was developed for superficial normal tissues in 
which the counter-current heat transfer occurs. In tumors, the vascular anatomy is different 
from the superficial normal tissues, and therefore a new model should be derived for 
tumors. Some (Wissler, 1987) has questioned the two basic assumptions of WJ model: first, 
that the arithmetic mean of the arteriole and venule blood temperature can be approximated 
by the mean tissue temperature; and second, that there is negligible heat transfer between 
the thermally significant arteriole-venule pairs and surrounding tissue.  
3.4 Thermally significant blood vessel model 
As CH and WJ models presented, many investigators (Baish et al, 1986; Charny and Levin, 
1990) during late 1980, questioned mostly on blood perfusion term or how to estimate blood 
temperature and local tissue temperatures where blood vessels (counter-current vessels) are 
involved. As arterial and veinous capillary vessels are small, their thermal contributions to 
local tissue temperatures are insignificant. However, some larger vessel sizes than the 
capillaries do have thermally significant impacts on tissue temperatures in either cooling or 
heating processes. Several investigators (Chato, 1980; Lagendijk, 1982; Huang et al, 1994) 
examined the effect of large blood vessels on temperature distribution using theoretical 
studies. Huang et al (Huang et al, 1996) in 1996 presented a more fundamental approach to 
model temperatures in tissues than do the generally used approximate equations such as the 
Pennes’ BHTE or effective thermal conductivity equations. As such, this type of model can 
be used to study many important questions at a more basic level. For example, in the 
particular hyperthermia application studied herein, a simple vessel network model predicts 
that the role of counter current veins is minimal and that their presence does not 
significantly affect the tissue temperature profiles: the arteries, however, removed a 
significant fraction of the power deposited in the tissue. The Huang’s model used a simple 
convective energy balance equation to calculate the blood temperature as a function of 
position, 
 ( )bi b ap i i b w
i
dT
M c Q h A T T
dx
= − −   (5) 
Here, iM
  is the mass flow rate of blood in artery i, cb is the specific heat of blood, Tb(xi) is 
the average blood temperature at position xi, xi indicates the direction along the vessel I 
(either x, y or z depending on the vessel level). apQ
  is the applied power deposition xi, hi is 
the heat transfer coefficient between the blood and the tissue, Ai is the perimeter of blood 
vessel i, and Tw(xi) is the temperature of the tissue at the vessel wall. For the smallest, 
terminal arterial vessels a decreasing blood flow rate is present giving the energy balance 
equation, 
 ( )b ii b ap i i b w b b
i i
dT dM
M c Q h A T T c T
dx dx
= − − −   (6) 
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The blood leaving these terminal arterial vessels at any cross-section is assumed to perfuse 
the tissue at a constant rate. The detailed description is shown in Huang (Huang et al, 1996). 
As to venous thermal model, for all of veins except the smallest terminal veins, the above 
equation (5) holds. For the smallest veins, the Tb replaced by the venous return temperature, 
Tvr(xi). In the presented study this temperature is taken to be average temperature of four 
tissue nodes adjacent to the terminal vein in the plane perpendicular to that vein, 
 
4
,
1
1
4
vr i adj
i
T T
=
= ∑  (7) 
For tissue matrix thermal equations, they can be explained most succinctly by considering 
the Pennes Bio-Heat Transfer Equation as the most general formulation, 
 2 ( )b a apk T Wc T T Q− ∇ + − =   (8) 
Here, k is the thermal conductivity of the tissue matrix, T(x,y,z) is the tissue temperature, 
W  is the “perfusion” value and Ta is the arterial blood temperature at some reference 
location. 
3.5 Others 
A few studies (Leeuwen et al, 2000; Devashish and Roemer, 2006; Baish, 1994) have modeled 
the effect of collections of a large number of parallel vessels or of networks of vessels on the 
resulting temperature distributions. Those were developed in attempt to describe the impact 
of blood vessels and to properly predict heat transfer processes in bio-thermal systems in a 
more accurate way. 
4. Numerical modelings 
As mentioned above the mathematical models for actual thermal problems of interest in 
hyperthermia or thermal ablation are too complicated to be conveniently solved with exact 
formulas. The majority of unsolved problems in medical fields is governed by non-linear 
partial differential equations. In most cases, one thereby reduces the problems to rather 
simplified models which can be exactly analyzed, for example, analytical solution of the 3D 
Pennes equation presented by Liu (Liu, 2001; Liu and Deng, 2002) using multidimensional 
Green function, and 1D transient Pennes equation by Shih et. al. (Shih et al, 2007) using the 
Laplace transform. But occasionally such an approach does not suffice. Consequently, 
specialists have recently devoted increasing attention to numerical, as opposed to analytical, 
techniques. Nowadays one of the major challenges for thermal ablation and hyperthermia 
simulation is the incorporation of the very detailed information coming from biophysical 
models into the numerical simulations. Thanks to advanced imaging techniques, accurate 
tumor static models including detailed description of all vascular matrix objects are 
currently available. Unfortunately, most of the discretization methods commonly used in 
computer simulation, mainly based on structured grids, are not capable to represent the 
detailed geometry of such treatment regions or other complicated entities such as 
microvascular matrix, horizontal wells, and uniformity, etc. The complexity of 
multidimensional heat transfer problems in hyperthermia suggests the application of 
numerical techniques. Several numerical methods have been used in engineering and 
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science fields; finite difference method, finite element method, finite volume approach, etc. 
(Morton and Mayers, 2005; Derziger, Peric, 2001; Thomas, 1995; Minkowycz et al, 1988; 
Anderson et al, 1984). 
4.1 Finite difference method 
Several mathematical models were discussed above to describe the continuum models of 
heat transfer in living biological tissue, with blood flow and metabolism. The general form 
of these equations is given by: 
 ( )b b a
DT T
c c V T k T w c T T Q
Dt t
ρ ρ ∂⎛ ⎞= + •∇ = ∇ • ∇ − − +⎜ ⎟∂⎝ ⎠
 (9) 
The partial differential equations for thermal ablation or hyperthermia are discretized at the 
grid point by using the finite difference approximation using Pennes equation.  
 2 ( )b b a
T
c k T w c T T Q
t
ρ ∂ = ∇ − − +∂  (10) 
The Pennes equation is solved with the finite difference formulation when the exact 
geometry is not particularly important or when the fundamental behavior of a bio-thermal 
system is analyzed, in particular with heterogeneous and at times anisotropic thermal 
properties. Define an Nx x Ny x Nz lattice in the (x, y, z) plane that spans our region of 
interest in 3D with dimension of Lx x Ly x Lz as shown in Figure 2. Let Nx, Ny and Nz be the 
numbers of equally spaced grid points in the x-, y-, and z-directions, respectively, and {xijk := 
(i∆x, j∆y, k∆z)} the grid points in the computational domain, where ∆x = Lx/Nx, ∆y = Ly/Ny, 
and ∆z = Lz/Nz. 
 
 
          nz              
X                               ny 
Liver
Z
Y nx
(i,j,k+1) 
(i,j-1,k)        (i-1,j,k) 
 
(i+1,j,k)         (i,j,k) 
(i,j,k-1)  
Fig. 1. Schematic representation of the grid system using a finite difference scheme 
In a typical numerical treatment, the dependent variables are described by their values at 
discrete points (a lattice) of the independent variables (e.g. space and/or time), and the 
partial differential equation is reduced to a large set of difference equations. It would be 
useful to revise our description of difference equations. Let Γ  be the elliptic operator and Π  
a finite difference approximation of Γ  with pth order accuracy, i.e., 
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 2 b bT k T w c TΓ = ∇ −  (11) 
( )pT T O hΠ ≈ Γ +  
where h = max{∆x, ∆y, ∆z}. Then the semi-discrete equation corresponding to Equation (11) 
reads b b a
T
c T Q w c T
t
ρ ∂ = Π + +∂ . To integrate in time, one can use the two-level implicit time-
stepping scheme: 
 
1
11 1
2 2
n n
n n n
b b a
T T
c T T Q w c T
t
ρ
+ +− ⎛ ⎞= Π + + +⎜ ⎟Δ ⎝ ⎠  (12) 
where ∆t is the time step size and Tn is the discrete solution vector at time tn = n∆t. This 
numerical scheme is known as the Crank–Nicolson scheme (Crank and Nicolson, 1947). It 
yields a truncation error at the nth time-level: ( )2 pError O t h= Δ + . In the matrix form we 
can represent (2) as: 
 1 ( )
2 2
n n n
b b a
t t t
I T I T Q w c T
c c cρ ρ ρ
+⎛ ⎞ ⎛ ⎞Δ Δ Δ− Π = + Π + +⎜ ⎟ ⎜ ⎟⎝ ⎠ ⎝ ⎠  (13) 
 
That is at time tn+1 the discrete solution is given by: 
 
1
1 ( )
2 2
n n n
b b a
t t t
T I I T Q w c T
c c cρ ρ ρ
−
+ ⎡ ⎤⎛ ⎞ ⎛ ⎞Δ Δ Δ= − Π + Π + +⎢ ⎥⎜ ⎟ ⎜ ⎟⎝ ⎠ ⎝ ⎠⎣ ⎦
 (14) 
Obviously other standard techniques for numerical discretization in time have also been 
used. For instance the unconditionally stable Alternating Direction Implicit (ADI) finite 
difference method (Peaceman and Rachford, 1955) was successfully used in the solution of 
the bio-heat equation in (Qi and Wissler, 1992; Yuan et al, 1995). 
4.2 Finite element method 
When an analysis is performed in complex geometries, the finite element method (Dennis et 
al, 2003; Hinton and Owen, 1974) usually handles those geometries better than finite 
difference. In the finite element method the domain where the solution is sought is divided 
into a finite number of mesh elements. (for example, a pyramid mesh, as shown in Figure 3). 
Applying the method of weighted residual to Pennes equation with a weight function, ω, 
over a single element, eΛ  results in: 
 
 ( ) 0
e
b b a e
T
c k T w c T T Q d
t
ω ρ
Λ
∂⎡ ⎤−∇ • ∇ + − − Λ =⎢ ⎥∂⎣ ⎦∫v  (15) 
 
A large but finite number of known functions are proposed as the representation of the 
temperature. The (shape) functions are constructed from simple interpolation functions 
within each element into which the domain is divided. The value of the function 
everywhere inside the element is determined by values at the nodes of that element. The 
temperature can be expressed by, 
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 ( ) ( ) ( ) ( )
1
, , , , ,
Nr
e
i i
i
T x y z t N x y z T t
=
=∑  (16) 
Or in a matrix form, ( ) ( ) ( ) ( ){ }, , , , ,eT x y z t N x y z T t⎡ ⎤= ⎣ ⎦  
 
 
3D element  
Liver
Z
Y
X
 
Fig. 2. Schematic representation of the mesh element system using a finite element scheme 
In Eq. (16), i , is an element local node number, Nr is the total number of element nodes and 
N(x,y,z) is the shape function associated with node i. Applying integration by parts into Eq. 
(15) one can obtain 
 
^
( ) ( ) 0
e e e
b b a e i e i e
T
c w c T T Q d k T N d k T n N d
t
ω ρ ω ω
Λ Λ Γ
∂⎡ ⎤+ − − Λ + ∇ •∇ Λ − ∇ • Γ =⎢ ⎥∂⎣ ⎦∫ ∫ ∫v  (17) 
Here, eΓ  is the surface element. Using the Galerkin method, the weight function, ω, is 
chosen to be the same as the interpolation function for T. Evaluation of each element and then 
assembling into the global system of linear equations for each node in the domain yields  
[ ] [ ]{ } [ ]{ } { } { }M T K T W T R P•⎧ ⎫ + + = +⎨ ⎬⎩ ⎭ , 
or [ ] [ ]{ } { }M T A T B•⎧ ⎫ + =⎨ ⎬⎩ ⎭  
where 
e
ij i j eM cN N dωρ
Λ
= Λ∫ , ( )
e
ij i j eK k N N dω
Λ
= ∇ •∇ Λ∫ , 
e
ij b b i j eW W c N N dω
Λ
= Λ∫ , 
^
1
( )
e
Nr
i j j i e
j
P k T N n N dω
=Γ
= ∇ • Γ∑∫ , 
e
i i i eR Q N dω
Λ
= Λ∫ , ij ij ijA K W= + , i i iB R P= +  
This set of equations cane be solved with any kind on numerical integration in time to 
obtain the approximate temperature distribution in the domain. For instance one can use the 
Crank-Nicolson algorithm, 
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 [ ] [ ] { } [ ] [ ] { } { } { }( )1 11 1 1 1 1
2 2 2
n n n nA M T A M T B B
t t
+ +⎛ ⎞ ⎛ ⎞+ = + + +⎜ ⎟ ⎜ ⎟Δ Δ⎝ ⎠ ⎝ ⎠  (18) 
where the superscript n+1 denotes the current time step and the superscript n, the previous 
time step. 
4.3 Finite volume method 
Finite volume methods are based on an integral form instead of a differential equation and 
the domains of interest are broken into a number of volumes, or grid cells, rather than 
pointwise approximations at grid points. Some of the important features of the finite volume 
method are thus similar to those of the finite element method (Oden, 1991). The basic idea of 
using finite volume method is to eliminate the divergence terms by applying the Gaussian 
divergence theorem. As a result an integral formulation of the fluxes over the boundary of 
the control volume is then obtained. Furthermore they allow for arbitrary geometries, using 
structured or unstructured meshing cells. An additional feature is that the numerical flux is 
conserved from one discretization cell to its neighbor. This characteristic makes the finite 
volume method quite attractive when modeling problems for which the flux is of 
importance, such as in fluid dynamics, heat transfer, acoustics and electromagnetic 
simulations, etc.  
Since finite volume methods are especially designed for equations incorporating divergence 
terms, they are a good choice for the numerical treatment of the bio-heat-transfer-equation. 
The computational domain is discretized into an assembly of grid cells as shown in Figure 4. 
 
                             3D volume 
Liver
Z 
X 
Y
 
Fig. 3. Schematic representation of the grid cell system using a finite volume scheme 
Then the governing equation is applied over each control volume in the mesh. So the 
volume integrals of Pennes equation can be evaluated over the control volume surrounding 
node i as 
 ( ) 0b b a
i
T
c k T w c T T Q d
t
ρ
Ω
∂⎡ ⎤−∇ • ∇ + − − Ω =⎢ ⎥∂⎣ ⎦∫v  (19) 
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By the use of the divergent theorem, 
 [ ] ( )ˆ
i i
j j
i
k T d k T n d q n d
Ω Γ Γ
−∇ • ∇ Ω = − ∇ • Γ = Γ∫ ∫ ∫v  (20) 
where the heat flux q k T= − ∇  and  
i
i
i
TT
c d c
t t
ρ ρ
Ω
∂∂⎡ ⎤ Ω ≅⎢ ⎥∂ ∂⎣ ⎦∫ ∩v , b b b b i ii w c Td w c TΩ Ω ≅∫ ∩v , [ ] ( )b b a i b b a ii Q w c T d Q w c TΩ + Ω ≅ +∫ ∩v  
where i∩  is the volume of the control volume, iT  and iQ  represent the numerical 
calculated temperature and source term at node i, respectively. The boundary integral 
presented in equation (a) is computed over the boundary of the control volume, iΩ , that 
surrounds node i using an edge-based representation of the mesh, i.e. 
 
i
j j ij j ij j
all edges all edges
q n d G q H q
Γ
Γ ≅ +∑ ∑∫  (21) 
where ijG  denotes the coefficients that must be applied to the edge value of the flux jq in 
the xj direction to obtain the contribution made by the edge to node i and ijH  represents the 
boundary edges coefficients that relate to the boundary edge flux jq  when the edge lies on 
the boundary, where ijH =0 on all edges except on the domain boundaries. The 
approximation of jq  on edge is evaluated by different schemes based on the temperatures 
between nodes. For example,  
j i
j
ij
T T
q
d
−=  
where ijd  is the distance between the center of the cells i and j. 
The semi-discrete form of the transient bioheat heat transfer equation represents a coupled 
system of first order differential equations, which can be rewritten in a compact matrix 
notation as 
 TP RT S
t
∂ + =∂  (22) 
with an initial condition. In equation (22), P represents the heat capacity matrix which is a 
diagonal matrix. R is the conductivity matrix including the contributions from the surface 
integral and perfusion terms. The vector S is formed by the independent terms, which arises 
from the thermal loads and boundary conditions. T is the vector of the nodal unknowns. 
Equation (22) can be further discretized in time to produce a system of algebraic equations. 
With the objective of validating the finite volume formulation described, one can use the 
simplest two-level explicit time step and rewrite equation (22) as the following expression 
 
1n n
n nT TP RT S
t
+ − + =Δ  (23) 
where 1n nt t t+Δ = −  is the length of the time interval and the superscripts represent the time 
levels. Such scheme is just first order accurate in time and the tΔ  must be chosen according 
to a stability condition (Lyra, 1994). Other alternatives, such as the generalized trapezoidal 
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method (Lyra, 1994; Zienkiewicz & Morgan, 1983), multi-stage Runge-Kutta scheme (Lyra, 
1994) can be implemented if higher-order time accuracy is required. 
4.4 Others 
Other classes of methods have also been applied to the partial differential equations, such as 
boundary element method (Wrobel and Aliabadi, 2002), spectral method (Canuto et al, 
2006), multigrid method (Briggs et al, 2000) ect. 
5. Heating methods 
Heating in bio-thermal systems that have many forms, they can be appeared in different 
power deposition calculations in PBHTE. They can be classified into three types which are 
invasive, minimal invasive and non-invasive methods. We introduced most clinical methods 
here.  
5.1 Hyperthermia  
Hyperthermia is a heat treatment, and traditionally refers to raise tissue temperatures to 
therapeutic temperatures in the range of 41~45°C (significantly higher than the usual body-
temperature) by external means. In history, the first known, more than 5000 years old, 
written medical report from the ancient Egypt mentions hyperthermia (Smith, 2002). Also, 
an ancient tradition in China, “Palm Healing”, has used the healing properties of far infrared 
rays for 3000 years. As our bodies radiate far infrared energy through the skin at 3 to 50 
microns, with a peak around 9.4 microns, these natural healers emit energy and heat radiating 
from their hands to heal. It could be applied in several various treatments: cure of common 
cold (Tyrrell et al, 1989), help in the rheumatic diseases (Robinson et al, 2002; Brosseau et al, 
2003) or application in cosmetics (Narins & Narins, 2003) and for numerous other indicators.  
5.2 Thermal ablation 
The differentiation between thermal ablation and hyperthermia relates to the treatment 
temperature and times. Thermal ablation usually refers to heat treatments delivered at 
temperatures above 55°C for short periods of time (i.e. few seconds to 1 min.). Hyperthermia 
usually refers to treatments delivered at temperatures around 41-45°C for 30~60 minutes. 
The goal of thermal ablation is to destroy entire tumors, killing the malignant cells using 
heat with only minimal damage to surrounding normal tissues. The principle of operation of 
the thermal ablation techniques is that to produces a concentrated thermal energy (heating 
or freezing), creating a hyperthermic/hypothermic injury, for example, by a needle-like 
applicator placed directly into the tumor or using focused ultrasound beams. Thermal 
ablation comprises several distinct techniques as shown in Figure 1: radiofrequency (RF) 
ablation, microwave ablation, laser ablation, cryoablation, and high-intensity focused 
ultrasound ablation. To have a good treatment, it is also crucial to destroy a thin layer of 
tissue surrounding the tumor because of the uncertainty of tumor margin and the possibility 
of microscopic disease (Dodd et al, 2000). 
When it is not applicable for patients to surgery, one of alternative therapies for malignant 
tumors is thermal ablation. It is a technique that provides clinicians and patients a 
repeatable, effective, low cost, and safe treatment to effectively alleviate, and in some cases 
cure, both primary and metastatic malignancies. However, the common procedures for each 
thermal ablation technique are not yet clearly defined because the decision to use ablation, 
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and which ablation technique to use, depends on several factors. In practice, the decision of 
whether to use thermal ablation depends on the training and preference of the physician in 
charge and the equipment resources available at his/her medical center. Moreover, physical 
characteristics of the treatment zone using ablation are also needed to concern, including the 
zone shape, uniformity, and its location. Up to now clinical results have been indicated that 
the different techniques of thermal ablation have roughly equivalent effectiveness for 
treating various tumors.  
 
 Liver 
Radiofrequency Ablation 
Freq=460~500 kHz  
Needle electrode 
 
(a) 
Microwave Ablation 
Freq ~2450MHz, Bipolar 
antenna needle 
Liver
(b) 
 
Liver 
Laser Ablation 
Nd-YAG Laserν=1064nm 
Optical fibe
(c) 
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Liver
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Argon (gas) or N2 (liquid) 
Cryoprobe 
 
(d) 
 
HIFU Ablation,  Freq=0.5~5MHz  
Transducer (Focused/Phased array) 
Liver 
(e) 
Fig. 4. Schematics of different thermal ablation techniques. (a) RF ablation (b) Microwave 
ablation (c) Laser ablation (d) Cryoablation (e) HIFU ablation 
Patients referred for thermal ablation are initially evaluated in a clinic setting where the 
patient’s history and pertinent imaging information are reviewed. Meanwhile, the 
applicability of ablation and the risks and benefits of the procedure are also discussed. Prior 
to ablation, the evaluation is very similar to a surgical evaluation that any possible risks of 
bleeding or serious cardiopulmonary issues are considered. Side effects from thermal 
ablation are also discussed, including postablation syndrome—for example, a short term 
fever, discomfort, and anorexia. 
5.2.1 High-intensity focused ultrasound (HIFU) 
HIFU is a non-invasive power deposition method via mechanical oscillation motion of 
object molecules. One of important features in the heating methods is non-invasiveness and 
it reduces external surgical operations on body object. Thus this method has become a 
promising tool for localized tumor therapy. Compared to hyperthermia which lasts long 
period of treating time, HIFU referred as thermal surgery, could heat the target region 
elevated temperature up to 50~55°C within a short period of time (i.e. few seconds to 1 
min.). Another important feature is that this comparably higher temperature during 
treatment could cause thermal coagulation and thermal lesion. Therefore, precise location 
management and monitoring are required during clinic HIFU treatment to prevent 
irreversible heating process on tissues. Figure 1.e illustrated the method. 
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5.2.2 Radiofrequency (RF) ablation 
Radiofrequency ablation is a “minimally invasive” treatment method mostly for primary 
and metastatic liver tumors. It is becoming a promising treating method to replace surgical 
resection. A study (Solbiati et al, 2001) in 2001 of RF ablation in 117 patients has shown 1-, 2-
, and 3-year survival rates of 93%, 62%, and 41%, respectively. As compared to traditionally 
only low or 10-20 % of patients, those will have disease amenable to surgical resection due 
to limited hepatic reserve, high surgical risk, or unfavorable tumor location.  
The mechanics of RF ablation uses the electromagnetic energy which is converted to heat by 
ionic friction. Tissue damage can occur at temperatures above 43°C with long heating times 
of several hours (Sapateto and Dewey, 1984). Elevated tissue temperature to 50°C near the 
probe required 3-min of heating time. Traditional and commercial design of the probe uses 
17-gauge needles with active tip exposures of 1, 2 and 3 cm and the remainder of the needle 
is electrically insulated. Within the probe, water is circulated during the ablation procedure 
to cool tissue next to the probe and prevent tissue charring. Figure 1.a illustrated the 
method. 
5.2.3 Microwave (MW) ablation 
Microwave tumor ablation is also a “minimally invasive” treatment method. In contrast, 
while RF employs radio-frequency current to generate heat, MW ablation produces an 
electromagnetic wave that is emitted from a 14.5 gauge (standard) microwave antenna 
placed directly within the treatment site. The electromagnetic wave produces 60 W of power 
at a frequency ranging from 900 to 2450 MHz, which generate frictional heat from the 
agitation of polar water molecules (McTaggart and Dupuy, 2007; Liang and Wang, 2007; 
Simon et al, 2005). In principle the electromagnetic wave passes through the tissues, it 
causes polar water molecules to rapidly change their orientation in accordance with the 
magnetic field. Additionally, the design of MW antenna contributes significantly to the 
efficiency of MW therapy. Figure 1.b illustrated the method. 
5.2.4 Others 
Another interesting method to kill tumor cells is cryo-ablation, as shown in Figure 1.d. In 
contrast with other methods, cryo-ablation use lower temperature to ablate tumors. The 
procedure can be performed either by a laparoscopic or percutaneous approach under MRI, 
US or CT guidance. Cryoablation involves a number of freeze-thaw-freeze cycles with argon 
and helium gas (McTaggart and Dupuy, 2007). Gases are used to remove heat and induce 
thawing. It is used to treat lesions of the prostate, kidney, liver, lung, bone, and breast 
(Hayek et al, 2008; Orlacchio et al, 2005). As the tissue freezes, osmolarity increases and 
causes an imbalance of solutes between the intracellular and extracellular environments. 
Cellular death initially occurs through cellular dehydration and protein denaturization. 
6. Adjuvant to other tumor treatment modalities 
Although the effectiveness of hyperthermia alone as a cancer treatment may be not so 
promising, significant improvements in clinical trials using combined therapies with 
hyperthermia are observed. Recently, hyperthermia has been applied as an adjunctive 
therapy with various established cancer treatments such as radiotherapy, chemotherapy, 
and nano-particle drug treatments, etc. The combination therapies seem to be safe and 
effective approaches even when other treatments have failed. The rationale of combining 
www.intechopen.com
 
Heating in Biothermal Systems 
 
271 
chemotherapy or other therapies with hyperthermia is that the available armamenterium for 
tumor heating has been substantially improved. The potential to control power distributions 
in clinic has been significantly improved lately by the development of advanced imaging 
techniques (particularly, online magnetic resonance tomography), planning systems and 
other modeling tools. 
6.1 Radiotherapy 
The efficacy of standard radiotherapy for patients with different tumor sites, for example, 
cervical, gastrointestinal, and genitourinary tumors, might become poor because the local-
control rates after locoregional treatment are disappointingly low. To compensate this defect 
the combinations of radiotherapy with other therapies have been used. It has been known 
that hyperthermia probably is the strongest radiosensitizer known, with an enhancement 
factor of up to 5 (Kampinga and Dikomey, 2001). Although the exact mechanism why heat 
can cause cells more sensitive to radiation is not known, clinical results reveal that heat 
primarily interferes with the cells’ ability to deal with radiation-induced DNA damage 
(Kampinga and Dikomey, 2001; Roti, 2004). 
Clinical studies have shown that the combination of radiotherapy with hyperthermia 
increases cytotoxic effects and higher locoregional control rates. In the Netherlands 358 
patients with tumors of the bladder, cervix, or rectum were treated with radiotherapy alone 
(n=176) or radiotherapy plus hyperthermia (n=182) from 1990 to 1996. Results showed the 
complete-response rates were 39% after radiotherapy and 55% after radiotherapy plus 
hyperthermia (Van der Zee et al, 2000). Radiotherapy plus hyperthermia was superior to 
radiotherapy alone and improved tumor response and survival. 
Moreover, other clinical results of the combination of radiotherapy with hyperthermia are 
summarized in some recent studies (Wust et al, 2002; Van der Zee, 2002). The 
supplementary values of this combined therapy are from 41% to 61% in 3-year local control 
rate and from 27% to 51% in 3-year overall survival in cervix cancer, from 24% to 69% in 5-
year local control rate in lymph nodes of head-and-neck tumors, and from 24% to 42% in 3-
year overall survival in esophageal cancer. The differences reported for the other 
radiosensitizing agents (Horsman et al, 2006), insofar as there are clinical results, are in the 
range of 10% to 20%. Significant improvements in clinical outcomes by additional treatment 
with hyperthermia were also shown for cancer of the breast, brain, rectum, bladder, and 
lung, and for melanoma. 
Whether the combination of radiation and heat is given in a simultaneous or sequential 
schedule, the thermal enhancement will be dependent on the heating time and temperature 
of both tumors and normal tissues (Horsman and Overgaard, 2002 & 2007). 
Besides, hyperthermia has a direct cell-killing effect, specifically in insufficiently perfused 
parts of the tumor. Several randomized clinical trials have shown that the beneficial effect of 
hyperthermia, when added to radiotherapy, can be substantial, even while the temperature 
of 43°C that was thought to be necessary was not achieved in the whole tumor volume.  
The improvements in clinical outcomes, despite the inadequacy to heat the whole tumor 
volume to temperatures of 43°C, can be explained by the more recent findings that 
hyperthermia has more effects than just that of direct cell kill and radiosensitization. Several 
additional effects that become apparent at different temperatures between 39° and 45°C 
have been described: vascular damage resulting in secondary cell death; improvement f 
perfusion and oxygenation, which results in a better effect of radiation; and stimulation of 
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the immune system (Dewhirst et al, 2007). All these effects may contribute o the desired 
eventual effect, which (certainly when combined with RT) is he achievement of local control. 
Several phase III trials comparing radiotherapy alone or with hyperthermia have shown a 
beneficial effect of hyperthermia (with existing standard equipment) in terms of local 
control (eg, recurrent breast cancer and malignant melanoma) and survival (eg, head and 
neck lymph-node metastases, glioblastoma, cervical carcinoma). Therefore, further 
development of existing technology and elucidation of molecular mechanisms are justified. 
6.2 Chemotherapy 
The combination of hyperthermia and chemotherapy has demonstrated several advantages 
over chemotherapy alone. The architecture of the vasculature in solid tumors is often 
insufficient due to the rapid growth of tumor tissue compared to normal tissue and/or 
chaotic, resulting in regions with hypoxia and low pH levels, which is not found in normal 
tissue. When using a mild hyperthermia (temperatures < 42 C), heat results in vasodilatation 
which improves the oxygenation of tissue (Iwata et al, 1996). Results reveal that the changes 
in tumor oxygenation are temperature dependent. This relationship could possibly influence 
treatment outcome of thermo-chemotherapy when the activity of chemotherapeutic agents 
is known to be oxygen dependent. This improvement of the blood supply can increase the 
cell metabolism which allows a greater effect of the chemotherapeutic agent on the tumor 
cells. Besides, heat also improves the cellular permeability which leads to the increase of the 
drug uptake by the tumor cells and intracellular spaces, the reaction of chemotherapy with 
DNA, and the prevention of DNA repair (Herman et al, 1988).  
Moreover, the pathologic studies have shown that the enhanced drug cytotoxicity by 
heating induces both apoptosis and necrosis above a certain threshold temperature 
(Harmon et al, 1990; Yonezawa et al, 1996). In addition, several studies have also shown that 
some of the advantages of combining chemotherapy with hyperthermia are not only 
treating the primary cancers, but also reducing the risk of treatment-induced secondary 
cancers ( Kampinga and Dikomey, 2001; Hurt et al, 2004; Hunt et al, 2007). These factors 
make cells more sensitive to heat especially in low perfused tissues. Therefore, in addition to 
direct cytotoxicity, hyperthermia leads in vivo to a selective destruction of tumor cells in 
hypoxic and, consequently, acidic environment within parts of malignant tumors (Vaupel et 
al, 1989; Vaupel, 2004). 
More recent in vivo studies have demonstrated that the thermal enhancement of 
cytotoxicity of many chemotherapeutic agents is maximized with heat (Hahn, 1979; 
Marmor, 1979; Engelhardt, 1987; Dahl, 1988; Bull, 1984; Hildebrandt et al, 2002; Urano et al, 
1999). The positive results of thermo-chemotherapy are observed that the rate at which cells 
are killed by the drug increases with temperatures. Besides, the efficacy of thermo-
chemotherapy also depends on the treatment planning. In general, promising results 
indicate that patients need to take chemotherapeutic agents immediately before 
hyperthermia. However, some of agents like the antimetabolite gemcitabine, are taken prior 
to hyperthermia at least 24 h to achieve a synergistic effect in vitro and in vivo (Haveman et 
al, 1995; Van Bree et al, 1999).  
Although the working mechanism of thermo-chemotherapy is not fully understood, with 
the promising results of clinical trials and the thermal enhancement of drug cytotoxicity 
from pathologic studies, hyperthermia combined with chemotherapy has demonstrated as 
one of effective modalities in the present cancer treatment. 
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6.3 Nano-particle drug therapy 
The nanoparticles have been applied to facilitate drug delivery and to overcome some of the 
problems of drug delivery for cancer treatment. In the past, cancer therapies using 
anticancer drugs were dissatisfied and had major side effects. Because of their 
multifunctional character the nanoparticles can deliver larger and more effective doses of 
chemotherapeutic agents or therapeutic genes into malignant cells, minimize toxic effects on 
healthy tissues and then alleviate patients suffering from the side-effects of chemotherapy. 
Nanoparticles can be used to deliver hydrophilic drugs, hydrophobic drugs, proteins, 
vaccines, biological macromolecules, etc. Several nanoscale delivery devices, such as ceramic 
nanoparticles, virus, dendrimers (spherical, branched polymers), silica-coated micelles, cross 
linked liposomes, and carbon nanotubes (Portney and Ozkan, 2006) have been used to 
improve delivery of anticancer agents to tumor cells (Brigger el al, 2002). Some of the 
challenges in effectively delivering anticancer drugs have to be solved: how to ensure 
therapeutic drug molecules reach the targeted tumor, how to release them slowly over a 
longer period, and how to avoid the human immune system destroying them.  
Normally, the structure of a nanoparticle drug carrier has four elements. The first of them is 
the targeted chemotherapy drug, for example, docetaxel or Taxotere. The second is a matrix 
made of a biodegradable polymer (polylactic acid), which contains the anticancer drug and 
breaks down slowly so that the drug is released gradually over several days. The third 
element is a coating layer of polyethylene glycol, which is used to prevent from attacking by 
antibodies and macrophage cells of the human immune system. The final element is a 
targeted tag, in the form of special enzymes attached to the outer coating, which can form 
electrostatic or covalent bonds with positively charged agents and biomolecules. This tag 
allows the nanoparticles to bind directly to desired tumor cells but to bypass healthy tissues 
and eventually to reduce the side effects caused by most chemotherapy drugs. 
Several different drug delivery methods (Jain, 2005) have been shown their feasibility to 
treat human cancers. Lipid-based cationic nanoparticles (Cavalcanti et al, 2005), one of new 
promising tumor therapies, by loading suitable cytotoxic compounds can cause strong 
human immune responses and result in the destruction of tumor. Magnetic nanoparticles as 
the carrier have been used in cancer treatment avoiding side effects of conventional 
chemotherapy (Alexiou et al, 2006). Recent progress has been made in the application of 
nanoparticles to cancer treatment, including their use as delivery systems for potent 
anticancer drugs or genes, as well as agents for more advanced cancer treatment modalities, 
such as the combination treatments of radiotherapy, chemotherapy, and gene therapy with 
hyperthermia (Kong et al, 2000).  
6.4 Others 
Hyperthermia-regulated gene therapy 
Major factors determining the effectiveness of gene therapy are the method of gene delivery 
and the details of the therapeutic gene expression in the targeted tissue. Some researchers 
have reported that heat can not only enhance the immunogenicity of tumor cells (Kubista et 
al, 2002), but also regulate the heat-sensitive promoters in the region of interest (Ito et al, 
2003; Ito et al, 2006; Ito et al, 2004; Todryk et al, 2003). Heat shock proteins (HSPs) as 
sensitive promoters are recognized as significant participants in immune reactions (Kubista 
et al, 2002). Animal studies showed that the hyperthermia-regulated gene therapy using  
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hsp70 obtained strong prevention of tumor growth, complete regression of tumors, and the 
induction of systemic antitumor immunity in the cured mice (Ito et al, 2006; Ito et al, 2004; 
Todryk et al, 2003).  
These studies suggest that the combination gene therapy with hyperthermia using hsp70 
have great potential in cancer treatment. Nevertheless, results also suggested that 
inappropriate immune reactivity to hsp70 might lead to pro-inflammatory responses and 
the development of autoimmune disease. Moreover, endotoxin contamination has been 
reported to be responsible for the human hsp70 preparation (Gao & Tsan, 2003; Bausinger et 
al, 2002) and uncontrolled promoter activation by other than heat stressors for the HSP70B 
promoter system was found (Siddiqui et al, 2008). To have a safe and controllable gene 
therapy the unintentional activation of heat-responsive promoters should be avoided. 
Although some effects of heat shock proteins on the immunogenicity of tumor cells have 
been studied, more work is still needed before the hyperthermia-regulated gene therapy 
using hsp70 can applied into clinical cancer treatments. 
Recently, a combination of gene therapy with magnetic resonance imaging (MRI), high-
intensity focused ultrasound (HIFU) and a temperature-sensitive promoter is being 
evaluated in the cancer field (Moonen, 2007; Silcox et al, 2005; Plathow et al, 2005; Frenkel, 
2006; Rome et al, 2005; Walther & Stein, 2009). With the help of advanced imaging 
techniques one can noninvasively monitor the temperature field induced by a high-intensity 
focused ultrasound system and simultaneously regulate the gene expression in the 
treatment region. Results indicated that although the application of MRI-guided HIFU in 
gene therapy is promising, further technical requirements of the heating and monitoring 
systems for precise control are still needed. 
In recent molecular and biological investigations there have been novel applications such as 
gene therapy or immunotherapy (vaccination) with temperature acting as an enhancer, to 
trigger or to switch mechanisms on and off. However, for every particular temperature-
dependent interaction exploited for clinical purposes, sophisticated control of temperature, 
spatially as well as temporally, in deep body regions will further improve the potential. 
7. Conclusion 
Thermal transport in bio-thermal systems signifies that temperature management in living 
systems can help us in curing and treatment of ill conditions. In analytic perspective, efforts 
on mathematical and numerical modelings have showed great progrssing in calculating 
temperature distributions. Advance in computer technology is one of critical contributing 
factors. In clinical perspective, many thermal energy related experiments and tests that are 
adjuvant to other tumor treatment modalities have identified effectiveness in treatments. In 
this regard, the well knowledge of heat transfer process revealed significant in optimal 
controling temperature in bio-thermal systems. Thus it shows us another great research and 
career opportunities in this field.  
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